REMISE Study: REMnant Biospecimen Investigation in SEpsis
Key facts
- Who runs it
- University of Pittsburgh
- Where
- Pittsburgh, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 71 people enrolled
- Started
- 25 Oct 2022
- Ended
- 31 Dec 2023
- Type of study
- Observational
- Record updated
- 28 February 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Adult patient, at least 18 years of age
- Meeting Sepsis-3 criteria within 6 hours of admission
- Biospecimens obtained for routine clinical care and measurement
- Peripheral intravenous access
Who cannot take part
- Cardiac arrest,
- Stroke,
- Patients who do not have Sepsis-3
- Traumatic injury,
- Inability to consent or contact legal representative,
- Comfort measures only,
- Unable to obtain intravenous access, and/or
- Subject declines to participate
- No residual blood left in clinical sample
Where in United States
- University of PittsburghPittsburgh, United States
About the trial
What the trial wants to find out
In the REMISE is study, we will compare blood proteins, biomarkers, and other -omics prospectively collected from patients with sepsis from two sources, i.) remnant (discarded) samples from the clinical laboratory, and ii.) prospectively collected in UPMC Presbyterian hospital research coordinator specimen collected biospecimens.
Read full original descriptionShow less
Analyses will include traditional biomarkers, quantitative proteomics, metabolomics, lipidomics, transcriptomics, and pathogen genomic sequencing in both sets of samples. This data will allow the assessment of the feasibility, integrity, and scientific value of remnant samples compared to research coordinator samples collected at the bedside for mechanistic sepsis research.
The group in the trial
- Patients with Sepsis
Adult patients (18 years or older) meeting Sepsis-3 criteria within 6 hours of emergency department admission. Patients will be excluded with the following conditions: traumatic injury, cardiac arrest, stroke, comfort measures only.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 28 February 2024